Skip to main content
PepStack
Blutwerte · Marker

Resistin

Resistin · FIZZ3

Adipokine & Metabolische HormoneNüchtern erforderlichZeitabhängig
Einheit:
ng/mL

Resistin quantifies the level of a hormone involved in glucose metabolism and inflammation.

Reference Ranges

Reference
7–22ng/mL
7
22
LowNormalHigh
Reference
Unit · ng/mL

Reference ranges may vary based on age, sex, and health status.

Overview

Übersicht

Resistin is an adipokine primarily secreted by adipose tissue, involved in the regulation of glucose metabolism and insulin sensitivity. It is a cysteine-rich protein that plays a role in inflammatory processes and is associated with obesity and metabolic syndrome. Researchers have observed that resistin levels are elevated in obesity, contributing to insulin resistance and inflammation. Clinically, elevated resistin levels are linked to increased risk of type 2 diabetes, cardiovascular diseases, and certain cancers. Resistin is also implicated in the pathophysiology of obesity-related disorders, serving as a biomarker for metabolic dysfunction. In the context of athletic performance and biohacking, resistin may influence energy metabolism and inflammatory responses, potentially affecting recovery and adaptation to exercise. However, its role in longevity is less clear, with ongoing research needed to elucidate its impact. Caveats include potential confounders such as circadian rhythm variations and fasting status, which can influence resistin levels. Researchers found that resistin levels may vary throughout the day, and fasting conditions are recommended for accurate assessment.

Klinische Bedeutung

Elevated resistin levels indicate increased risk of insulin resistance, type 2 diabetes, and cardiovascular diseases. Low levels are less commonly associated with specific clinical conditions.

Dynamics

Trend Interpretation

Rising Values

Progressively rising resistin levels suggest worsening insulin resistance and increased inflammation. Re-test in 4 weeks if outside optimal range.

Falling Values

Falling resistin levels may indicate improved metabolic health and reduced inflammation.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Obesity
  • Insulin resistance
  • Chronic inflammation
  • Type 2 diabetes
  • Cardiovascular disease
  • Circadian misalignment
Cause

Low Levels

  • Healthy weight
  • Improved insulin sensitivity
  • Anti-inflammatory interventions
  • Weight loss
  • Exercise
  • Balanced diet
Protocol

How to Optimize

Lever

Lifestyle

  • Regular physical activity
  • Weight management
  • Stress reduction
  • Adequate sleep
Lever

Nutrition

  • Balanced diet rich in fruits and vegetables
  • Reduced intake of processed foods
  • Omega-3 fatty acids
  • High-fiber foods
Lever

Supplementation

  • Omega-3 supplements
  • Curcumin
  • Resveratrol

Note:

Consult with a healthcare provider before making significant lifestyle changes.

Testing Guidelines

🍽️Fasting Required
🕐Time-Sensitive

Resistin levels may vary; morning fasting samples are recommended.

Testing Frequency

Annually for individuals with metabolic risk factors.

Interfering Factors

  • Recent meal intake
  • Circadian rhythm disruptions
  • Acute stress

Related Peptides & Hormones

Adiponectin

Correlated with

hormone or peptide

Open Research Questions

Current research suggests that reference ranges for resistin levels in various populations, particularly in children and adolescents, remain poorly defined, and the optimal targets for therapeutic interventions are still debated. Researchers have not yet established the precise role of resistin in mediating obesity-related inflammation and its interactions with other adipokines. Additionally, clinical questions remain unanswered regarding the long-term implications of resistin levels on cardiovascular disease risk and metabolic syndrome progression in diverse demographics.

42 Research Publications

4,632

Total Citations

16

Human/RCT

7.3

Avg. Influence

2021

Latest

Sort
Filter
#01

Obesity and cancer risk: Emerging biological mechanisms and perspectives.

ReviewInfluence39.0
1283
This review examined the relationship between obesity and cancer risk, highlighting that excess body weight is linked to an increased risk of various cancers. Researchers found multiple biological mechanisms that connect obesity to cancer, including insulin resistance and inflammation.
View on PubMed
#02

Circadian misalignment increases cardiovascular disease risk factors in humans.

HumanInfluence16.0
633
This study investigated the effects of circadian misalignment on cardiovascular risk factors. Researchers observed that misalignment increased levels of inflammatory markers, including resistin, and elevated blood pressure in healthy adults.
View on PubMed
#03

Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases.

ReviewInfluence13.0
432
This study aimed to identify potential frailty biomarkers, including resistin, associated with aging and age-related diseases. Researchers proposed a biomarker panel that includes resistin as a candidate for assessing frailty in older adults.
View on PubMed
#04

Human resistin: found in translation from mouse to man.

ReviewInfluence9.0
312
Researchers examined the link between human resistin and metabolic diseases, noting its secretion by macrophages. They found that resistin serves as an inflammatory biomarker and may mediate diabetes and cardiovascular disease.
View on PubMed
#05

Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation.

ReviewInfluence6.0
234
Researchers investigated the role of adipokines, including resistin, in adipose tissue inflammation associated with obesity. They found that obesity leads to increased levels of pro-inflammatory adipokines, which may contribute to metabolic disorders.
View on PubMed
#06

Pomegranate and type 2 diabetes.

ReviewInfluence7.0
231
Researchers reviewed the effects of pomegranate on type 2 diabetes, noting that certain components can reduce resistin formation and improve metabolic variables. They highlighted the need for further clinical studies to validate these findings.
View on PubMed
#07

Resistin- and Obesity-associated metabolic diseases.

ReviewInfluence18.0
199
Researchers examined the relationship between resistin and metabolic diseases, noting that resistin is produced by macrophages in humans and may serve as a biomarker for inflammation and metabolic disorders.
View on PubMed
#08

Resistin in metabolism, inflammation, and disease.

Tripathi Deeksha, et al. · The FEBS journal · 2020

ReviewInfluence5.0
194
Researchers summarized the diverse roles of resistin in metabolism and inflammation, noting its involvement in insulin resistance and stress response. They highlighted resistin's potential as a biomarker for evaluating disease status.

Key findings

  1. 01Resistin has different functions in mice and humans, affecting metabolism and inflammation.
  2. 02In mice, resistin is associated with insulin resistance and type 2 diabetes.
  3. 03In humans, resistin is linked to inflammation and may serve as a biomarker for disease evaluation.
View on PubMed
#09

Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.

ReviewInfluence2.0
169
Researchers reviewed the interactions between adipokines, myokines, and hepatokines, emphasizing their roles in metabolic disorders. They found that pro-inflammatory adipokines, including resistin, are secreted more by overweight individuals, potentially contributing to diseases like type 2 diabetes and cardiovascular diseases.
View on PubMed
#10

Resistin: insulin resistance to malignancy.

ReviewInfluence8.0
142
This review highlighted resistin as an inflammatory biomarker linking obesity to various diseases, including cardiovascular conditions and cancer. Researchers discussed its potential role in mediating metabolic disturbances and its implications for diagnostics.
View on PubMed

Clinical Trials (4)

4

Total Trials

264

Total Enrolled

Metabolic and Hormonal Parameters in Women With Polyendocrine Metabolic Ovarian Syndrome

NCT07844785NOT_YET_RECRUITING
Sponsor

Istinye University

Enrollment

80

Started

2026

Primary outcome

Correlation Between Serum and Salivary Fetuin-A and Resistin Levels

Polycystic Ovary SyndromePolycystic Ovary Syndrome (PCOS) WomenFetuin-ASerum BiomarkersInsulin Resistance

Relationship Between Serum Resistin Levels and Reduction in Visceral Fat in Patients Undergoing Sleeve Gastrectomy Due to Morbid Obesity

NCT07564986COMPLETED
Sponsor

Sercan YUKSEL, MD

Enrollment

80

Started

2025

Primary outcome

Change in body mass index at 8 months

Morbid Obesity Requiring Bariatric Surgery

Beta-glucan-chitin-chitosan Polymer Supplement in Overweight/Obese Subjects: Cardiovascular Risk Biomarkers (QUITOVASC)

NCT06622447COMPLETED
Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Enrollment

60

Started

2017

Primary outcome

Adipokines Plasma Levels (Adiponectin, Leptin, Resistin) at Week 12

Dietary Exposure

Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.

NCT00339703COMPLETED
Sponsor

59th Medical Wing

Enrollment

44

Started

2004

Asthma

Publication Trend

Research publications about Resistin over time

10total
1
'09
1
'11
1
'13
1
'15
1
'16
1
'17
2
'19
1
'20
1
'24

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer